Jury Hits Takeda With $2M In Damages In Philly Actos Case
A Philadelphia jury slapped Takeda Pharmaceutical Co. Ltd. with over $2 million in damages Friday afternoon after finding that the diabetes drug Actos had contributed to a plaintiff's bladder cancer and...To view the full article, register now.
Already a subscriber? Click here to view full article